Quick Answer
Esperion Therapeutics, Inc. reported Common Stock Shares Outstanding of 27.50 million shares for the year ending 2019.
- Esperion Therapeutics, Inc. showed an increase of +2.5% in Common Stock Shares Outstanding from 2018 to 2019.
- This data is from Esperion Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2021.
- XBRL data for this metric is available from 2012 to 2019 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: 372,079 shares | Q3 2013: 15.34 million shares | Q1 2014: 15.38 million shares | Q2 2014: 15.43 million shares | Q3 2014: 15.44 million shares | Q1 2015: 22.45 million shares | Q2 2015: 22.48 million shares | Q3 2015: 22.51 million shares | Q1 2016: 22.54 million shares | Q2 2016: 22.54 million shares | Q3 2016: 22.55 million shares | Q1 2017: 22.59 million shares | Q2 2017: 22.59 million shares | Q3 2017: 26.19 million shares | Q1 2018: 26.75 million shares | Q2 2018: 26.80 million shares | Q3 2018: 26.80 million shares | Q1 2019: 26.91 million shares | Q2 2019: 27.04 million shares | Q3 2019: 27.18 million shares | Q1 2020: 27.55 million shares | Q2 2020: 27.75 million shares | Q3 2020: 27.86 million shares.
- Over the full 8 years of available data (2012 to 2019), Esperion Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 7,836.4%.
- Historical annual values: Fiscal year 2019: 27.50 million shares | Fiscal year 2018: 26.82 million shares | Fiscal year 2017: 26.30 million shares | Fiscal year 2016: 22.56 million shares | Fiscal year 2015: 22.52 million shares | Fiscal year 2014: 20.34 million shares | Fiscal year 2013: 15.34 million shares | Fiscal year 2012: 346,478 shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: